a more favorable option for some patients Side Effects: Black Box Warning: RISK OF THYROID C-CELL TUMORS Reference: rxlist.com (Tanzeum) Dulaglutide Drug Name: Trulicity (FDA Approved 9/18/14) GLP-1 receptor agonist, hypoglycemic Pharmacokinetics: Long acting (half life: 5 days) subcutaneous pen injections weekly dosing (vs daily dosing for some other GLP-1 agonists such as exenatide, liraglutide & lixisenatide) a more favorable dosing option for some patients Side Effects: Black Box Warning: RISK OF THYROID C-CELL TUMORS References: Masharani U, Kroon L (2024): Pancreatic Hormones & Antidiabetic Drugs (Chapter 41)
Learn more about Motus on the product page: Motus by Tonum and review the study materials on the Motus study page: Motus study
Lyophilized peptide is stable at room temperature for several weeks
Side effects that occurred with a frequency of 1% or less included the following: Gastrointestinal: dyspepsia, flatulence, mucositis, oral moniliasis, and gastritis Nervous System: headache, somnolence Allergic: bronchospasm Special Senses: taste perversion Adverse events reported with azithromycin during the post-marketing period in adult and/or pediatric patients for which a causal relationship may not be established include: Allergic: Arthralgia, edema, urticaria and angioedema Cardiovascular: Arrhythmias including ventricular tachycardia and hypotension
Key Ingredients A strong liver support formula combining TUDCA, botanical extracts, amino acid support nutrients, and glutathione
GLP-1 medications work by mimicking a hormone involved in appetite, fullness, and blood sugar regulation